Rheumatologists in dispute with PBAC over pregabalin

Rheumatologists have disputed the PBAC’s claims that pregabalin is being prescribed for fibromyalgia outside of PBS criteria.  

Pregabalin (Lyrica) has been listed on the PBS since March 2013 for neuropathic pain, with the PBAC estimating it would benefit over 200,000 people every year.

But over 400,000 people were prescribed pregabalin between March 2014 and February 2015, according to the PBAC